Cocaine self-administration in dopamine-transporter knockout mice.
paper
Cited
Public
Unavailable
- Authors
- Rocha, B A; Fumagalli, F; Gainetdinov, R R; Jones, S R; Ator, R; Giros, B; Miller, G W; Caron, M G
- Year
- 1998
- Journal
- Nature neuroscience
- PMID
- 10195128
- DOI
- 10.1038/381
The plasma membrane dopamine transporter (DAT) is responsible for clearing dopamine from the synapse. Cocaine blockade of DAT leads to increased extracellular dopamine, an effect widely considered to be the primary cause of the reinforcing and addictive properties of cocaine. In this study we tested whether these properties are limited to the dopaminergic system in mice lacking DAT. In the absence of DAT, these mice exhibit high levels of extracellular dopamine, but paradoxically still self-administer cocaine. Mapping of the sites of cocaine binding and neuronal activation suggests an involvement of serotonergic brain regions in this response. These results demonstrate that the interaction of cocaine with targets other than DAT, possibly the serotonin transporter, can initiate and sustain cocaine self-administration in these mice.
No figures extracted from this document.
No chunks β full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
Not in any collection.
No citations found.
In this knowledge base
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Multilevel impact of cocaine on honeybees: From neurochemistry and mitochondrial dysfunction to superorganism. | KodrΓk D et al. | β | 2026 | β |
| Behavioural and pharmacokinetic analysis of heroin and cocaine self-administration: Effects of timeout on self-administration and choice in male rats. | D'Ottavio G et al. | β | 2025 | β |
| The Ins and Outs of Dopamine Transporter Gene Manipulation: In Vivo Models of DAT Dysfunction. | Stewart A et al. | β | 2025 | β |
| Differential Impact of Serotonin Signaling Methylphenidate on Young versus Adult: Insights from Behavioral and Dorsal Raphe Nucleus Neuronal Recordings from Freely Behaving Rats. | Dafny N et al. | β | 2024 | β |
| PEDOT/CNT Flexible MEAs Reveal New Insights into the Clock Gene's Role in Dopamine Dynamics. | Wu B et al. | β | 2024 | β |
| The dopamine hypothesis for ADHD: An evaluation of evidence accumulated from human studies and animal models. | MacDonald HJ et al. | β | 2024 | β |
| Associations Between Cognition and Serotonin 1B Receptor Availability in Healthy Volunteers: A [11C]AZ10419369 Positron Emission Tomography Study. | Tangen Γ et al. | β | 2023 | β |
| Dopamine Transporter Knockout Rats Display Epigenetic Alterations in Response to Cocaine Exposure. | Vilca S et al. | β | 2023 | β |
| Hypocretin / Orexin Receptor 1 Knockdown in GABA or Dopamine Neurons in the Ventral Tegmental Area Differentially Impact Mesolimbic Dopamine and Motivation for Cocaine. | Black EM et al. | β | 2023 | β |
| Who Knew? Dopamine Transporter Activity Is Critical in Innate and Adaptive Immune Responses. | Gopinath A et al. | β | 2023 | β |
| Zwitterionic Polymer Coated and Aptamer Functionalized Flexible Micro-Electrode Arrays for In Vivo Cocaine Sensing and Electrophysiology. | Wu B et al. | β | 2023 | β |
| Heterozygote Dopamine Transporter Knockout Rats Display Enhanced Cocaine Locomotion in Adolescent Females. | Pardo M et al. | β | 2022 | β |
| Long access to cocaine self-administration dysregulates the glutamate synapse in the nucleus accumbens core of serotonin transporter knockout rats. | Caffino L et al. | β | 2022 | β |
| Machine Learning Analysis of Cocaine Addiction Informed by DAT, SERT, and NET-Based Interactome Networks. | Feng H et al. | β | 2022 | β |
| Substance abuse and neurotransmission. | Davis S et al. | β | 2022 | β |
| Activation of proline metabolism maintains ATP levels during cocaine-induced polyADP-ribosylation. | Dash S et al. | β | 2021 | β |
| An optimized procedure for robust volitional cocaine intake in mice. | LΓ³pez AJ et al. | β | 2021 | β |
| Disrupted PDZ-domain binding motif of the dopamine transporter uniquely alters nanoscale distribution, dopamine homeostasis and reward motivation | SΓΈrensen G et al. | β | 2021 | β |
| Disruption of the PDZ domain-binding motif of the dopamine transporter uniquely alters nanoscale distribution, dopamine homeostasis, and reward motivation. | SΓΈrensen G et al. | β | 2021 | β |
| Genetic basis of variation in cocaine and methamphetamine consumption in outbred populations of <i>Drosophila melanogaster</i>. | Baker BM et al. | β | 2021 | β |
| Identification of the Risk Genes Associated With Vulnerability to Addiction: Major Findings From Transgenic Animals. | Jordan CJ et al. | β | 2021 | β |
| Increased serotonin prevents compulsion in addiction. | Miyazaki K et al. | β | 2021 | β |
| Is It Possible to Shift from Down to Top Rank? A Focus on the Mesolimbic Dopaminergic System and Cocaine Abuse. | Amaral IM et al. | β | 2021 | β |
| Neurokinin-1 Antagonism Distinguishes the Role of Norepinephrine Transporter from Dopamine Transporter in Mediating Amphetamine Behaviors. | Mannangatti P et al. | β | 2021 | β |
| Single Exposure to the Cathinones MDPV and Ξ±-PVP Alters Molecular Markers of Neuroplasticity in the Adult Mouse Brain. | Caffino L et al. | β | 2021 | β |
| Characterization of genetically complex Collaborative Cross mouse strains that model divergent locomotor activating and reinforcing properties of cocaine. | Schoenrock SA et al. | β | 2020 | β |
| Cocaine Self-Administration and Abstinence Modulate NMDA Receptor Subunits and Active Zone Proteins in the Rat Nucleus Accumbens. | Smaga I et al. | β | 2020 | β |
| Hypersensitivity to amphetamine's psychomotor and reinforcing effects in serotonin transporter knockout rats: Glutamate in the nucleus accumbens. | Caffino L et al. | β | 2020 | β |
| The Role of Dorsal Raphe Serotonin Neurons in the Balance between Reward and Aversion. | Nagai Y et al. | β | 2020 | β |
| Behavioral characterization of DAT-KO rats and evidence of asocial-like phenotypes in DAT-HET rats: The potential involvement of norepinephrine system. | Adinolfi A et al. | β | 2019 | β |
| Dopamine and addiction: what have we learned from 40Β years of research. | Solinas M et al. | β | 2019 | β |
| Hypofunctional Dopamine Uptake and Antipsychotic Treatment-Resistant Schizophrenia. | Amato D et al. | β | 2019 | β |
| Oestradiol influences on dopamine release from the nucleus accumbens shell: sex differences and the role of selective oestradiol receptor subtypes. | Yoest KE et al. | β | 2019 | β |
| Quantitative Systems Pharmacological Analysis of Drugs of Abuse Reveals the Pleiotropy of Their Targets and the Effector Role of mTORC1. | Pei F et al. | β | 2019 | β |
| The Effects of Amphetamine and Methamphetamine on the Release of Norepinephrine, Dopamine and Acetylcholine From the Brainstem Reticular Formation. | Ferrucci M et al. | β | 2019 | β |
| A single cocaine administration alters dendritic spine morphology and impairs glutamate receptor synaptic retention in the medial prefrontal cortex of adolescent rats. | Caffino L et al. | β | 2018 | β |
| Cocaine Inhibition of Synaptic Transmission in the Ventral Pallidum Is Pathway-Specific and Mediated by Serotonin. | Matsui A et al. | β | 2018 | β |
| Prenatal cocaine exposure disrupts the dopaminergic system and its postnatal responses to cocaine. | Riley E et al. | β | 2018 | β |
| Pronounced Hyperactivity, Cognitive Dysfunctions, and BDNF Dysregulation in Dopamine Transporter Knock-out Rats. | Leo D et al. | β | 2018 | β |
| Alpha-synuclein modulates dopamine neurotransmission. | Butler B et al. | β | 2017 | β |
| Aptamer-functionalized neural recording electrodes for the direct measurement of cocaine in vivo. | Taylor IM et al. | β | 2017 | β |
| A single cocaine exposure disrupts actin dynamics in the cortico-accumbal pathway of adolescent rats: modulation by a second cocaine injection. | Caffino L et al. | β | 2017 | β |
| Differential effects of aprepitant, a clinically used neurokinin-1 receptor antagonist on the expression of conditioned psychostimulant versus opioid reward. | Mannangatti P et al. | β | 2017 | β |
| Glial and Neuroimmune Mechanisms as Critical Modulators of Drug Use and Abuse. | Lacagnina MJ et al. | β | 2017 | β |
| HIV, Tat and dopamine transmission. | Gaskill PJ et al. | β | 2017 | β |
| Dopamine transporter mutant animals: a translational perspective. | Efimova EV et al. | β | 2016 | β |
| "TAARgeting Addiction"--The Alamo Bears Witness to Another Revolution: An Overview of the Plenary Symposium of the 2015 Behavior, Biology and Chemistry Conference. | Grandy DK et al. | β | 2016 | β |
| The Emergence of a Circuit Model for Addiction. | LΓΌscher C | β | 2016 | β |
| A single exposure to cocaine during development elicits regionally-selective changes in basal basic Fibroblast Growth Factor (FGF-2) gene expression and alters the trophic response to a second injection. | Giannotti G et al. | β | 2015 | β |
| Classic Studies on the Interaction of Cocaine and the Dopamine Transporter. | Verma V | β | 2015 | β |
| Cocaine increases dopaminergic neuron and motor activity via midbrain Ξ±1 adrenergic signaling. | Goertz RB et al. | β | 2015 | β |
| Dopamine Transporter Activity Is Modulated by Ξ±-Synuclein. | Butler B et al. | β | 2015 | β |
| Involvement of reactive oxygen species in cocaine-taking behaviors in rats. | Jang EY et al. | β | 2015 | β |
| Psychostimulants affect dopamine transmission through both dopamine transporter-dependent and independent mechanisms. | Dela PeΓ±a I et al. | β | 2015 | β |
| Serotonin and conditioning: focus on Pavlovian psychostimulant drug conditioning. | Carey RJ et al. | β | 2015 | β |
| Social stress and escalated drug self-administration in mice II. Cocaine and dopamine in the nucleus accumbens. | Han X et al. | β | 2015 | β |
| The neurosteroid dehydroepiandrosterone sulfate, but not androsterone, enhances the antidepressant effect of cocaine examined in the forced swim test--Possible role of serotonergic neurotransmission. | Krzascik P et al. | β | 2015 | β |
| The rise (and fall?) of drug discrimination research. | McMahon LR | β | 2015 | β |
| The role of mesoaccumbens dopamine in nicotine dependence. | Balfour DJ | β | 2015 | β |
| Designing modulators of 5-hydroxytryptamine signaling to treat abuse disorders. | van de Wiel SM et al. | β | 2014 | β |
| In vivo amphetamine action is contingent on Ξ±CaMKII. | Steinkellner T et al. | β | 2014 | β |
| Restoration of cocaine stimulation and reward by reintroducing wild type dopamine transporter in adult knock-in mice with a cocaine-insensitive dopamine transporter. | Wu H et al. | β | 2014 | β |
| Serotonin/dopamine interactions in a hyperactive mouse: reduced serotonin receptor 1B activity reverses effects of dopamine transporter knockout. | Hall FS et al. | β | 2014 | β |
| Altered reward circuitry in the norepinephrine transporter knockout mouse. | Gallagher JJ et al. | β | 2013 | β |
| Capillary electrophoresis-mass spectrometry-based detection of drugs and neurotransmitters in Drosophila brain. | Phan NT et al. | β | 2013 | β |
| Drug-evoked synaptic plasticity causing addictive behavior. | LΓΌscher C | β | 2013 | β |
| Dynamic modulation of basic Fibroblast Growth Factor (FGF-2) expression in the rat brain following repeated exposure to cocaine during adolescence. | Giannotti G et al. | β | 2013 | β |
| Implications of genome wide association studies for addiction: are our a priori assumptions all wrong? | Hall FS et al. | β | 2013 | β |
| Modulation of the endocannabinoid system: vulnerability factor and new treatment target for stimulant addiction. | OliΓ¨re S et al. | β | 2013 | β |
| Oral administration of methylphenidate blocks the effect of cocaine on uptake at the Drosophila dopamine transporter. | Berglund EC et al. | β | 2013 | β |
| Pain and suicidality: insights from reward and addiction neuroscience. | Elman I et al. | β | 2013 | β |
| SLC6 transporters: structure, function, regulation, disease association and therapeutics. | Pramod AB et al. | β | 2013 | β |
| The effects of the 5-HT3 receptor antagonist tropisetron on cocaine-induced conditioned taste aversions. | Briscione MA et al. | β | 2013 | β |
| The membrane raft protein Flotillin-1 is essential in dopamine neurons for amphetamine-induced behavior in Drosophila. | Pizzo AB et al. | β | 2013 | β |
| The neurocircuitry of illicit psychostimulant addiction: acute and chronic effects in humans. | Taylor SB et al. | β | 2013 | β |
| Advancing addiction treatment: what can we learn from animal studies? | Wu PH et al. | β | 2012 | β |
| Domain-dependent effects of DAT inhibition in the rat dorsal striatum. | Mitch Taylor I et al. | β | 2012 | β |
| Dopamine mediates cocaine-induced conditioned taste aversions as demonstrated with cross-drug preexposure to GBR 12909. | Serafine KM et al. | β | 2012 | β |
| Morphine history sensitizes postsynaptic GABA receptors on dorsal raphe serotonin neurons in a stress-induced relapse model in rats. | Staub DR et al. | β | 2012 | β |
| Pharmacotherapeutics directed at deficiencies associated with cocaine dependence: focus on dopamine, norepinephrine and glutamate. | Haile CN et al. | β | 2012 | β |
| Quantitative pharmacologic MRI in mice. | Perles-Barbacaru TA et al. | β | 2012 | β |
| The aggregate effect of dopamine genes on dependence symptoms among cocaine users: cross-validation of a candidate system scoring approach. | Derringer J et al. | β | 2012 | β |
| The effects of haloperidol on cocaine-induced conditioned taste aversions. | Serafine KM et al. | β | 2012 | β |
| The nucleus accumbens 5-HTRβ-CART pathway ties anorexia to hyperactivity. | Jean A et al. | β | 2012 | β |
| The orphan receptor GPR3 modulates the early phases of cocaine reinforcement. | Tourino C et al. | β | 2012 | β |
| Contributions of serotonin in addiction vulnerability. | Kirby LG et al. | β | 2011 | β |
| Differentiating the rapid actions of cocaine. | Wise RA et al. | β | 2011 | β |
| Effect of genetic modifications in the synaptic dopamine clearance systems on addiction-like behaviour in mice. | TammimΓ€ki A et al. | β | 2011 | β |
| ELAV-GAP43 pathway activation following combined exposure to cocaine and stress. | Pascale A et al. | β | 2011 | β |
| Excited delirium. | Takeuchi A et al. | β | 2011 | β |
| False positive in the intravenous drug self-administration test in C57BL/6J mice. | Thomsen M et al. | β | 2011 | β |
| How addictive drugs disrupt presynaptic dopamine neurotransmission. | Sulzer D | β | 2011 | β |
| In utero exposure to cocaine delays postnatal synaptic maturation of glutamatergic transmission in the VTA. | Bellone C et al. | β | 2011 | β |
| Natural and engineered coding variation in antidepressant-sensitive serotonin transporters. | Ye R et al. | β | 2011 | β |
| Optogenetics: potentials for addiction research. | Cao ZF et al. | β | 2011 | β |
| Quantitative pharmacologic MRI: mapping the cerebral blood volume response to cocaine in dopamine transporter knockout mice. | Perles-Barbacaru TA et al. | β | 2011 | β |
| Regulation of monoamine transporters: Role of transporter phosphorylation. | Ramamoorthy S et al. | β | 2011 | β |
| Stress and cocaine interact to modulate Arc/Arg3.1 expression in rat brain. | Caffino L et al. | β | 2011 | β |
| Synthesis and pharmacological evaluation of 6-acetyl-3-(4-(4-(4-fluorophenyl)piperazin-1-yl)butyl)benzo[d]oxazol-2(3H)-one (SN79), a cocaine antagonist, in rodents. | Kaushal N et al. | β | 2011 | β |
| The Selective Serotonin Reuptake Inhibitor Paroxetine, but not Fluvoxamine, Decreases Methamphetamine Conditioned Place Preference in Mice. | Takamatsu Y et al. | β | 2011 | β |
| The synthesis and biological evaluation of 2-(3-methyl or 3-phenylisoxazol-5-yl)-3-aryl-8-thiabicyclo[3.2.1]octanes. | Purushotham M et al. | β | 2011 | β |
| Transgenic elimination of high-affinity antidepressant and cocaine sensitivity in the presynaptic serotonin transporter. | Thompson BJ et al. | β | 2011 | β |
| Ξ±-Synuclein stimulates a dopamine transporter-dependent chloride current and modulates the activity of the transporter. | Swant J et al. | β | 2011 | β |
| A pair of dopamine neurons target the D1-like dopamine receptor DopR in the central complex to promote ethanol-stimulated locomotion in Drosophila. | Kong EC et al. | β | 2010 | β |
| Behavioral evidence for the significance of serotoninergic (5-HT) receptors in cocaine addiction. | Filip M et al. | β | 2010 | β |
| Dopamine, norepinephrine and serotonin transporter gene deletions differentially alter cocaine-induced taste aversion. | Jones JD et al. | β | 2010 | β |
| Drug-driven AMPA receptor redistribution mimicked by selective dopamine neuron stimulation. | Brown MT et al. | β | 2010 | β |
| Evidence of long-term expression of behavioral sensitization to both cocaine and ethanol in dopamine transporter knockout mice. | Morice E et al. | β | 2010 | β |
| Motivation on the Mediterranean: reward, compulsions and habit formation. | John CE et al. | β | 2010 | β |
| Neurocircuitry of addiction. | Koob GF et al. | β | 2010 | β |
| Regulation of the dopamine transporter: aspects relevant to psychostimulant drugs of abuse. | Schmitt KC et al. | β | 2010 | β |
| Simultaneous monitoring of dopamine concentration at spatially different brain locations in vivo. | Zachek MK et al. | β | 2010 | β |
| Transgenic mice in the study of drug addiction and the effects of psychostimulant drugs. | Sora I et al. | β | 2010 | β |
| Behavioral and neurochemical effects of amphetamine analogs that release monoamines in the squirrel monkey. | Kimmel HL et al. | β | 2009 | β |
| Changes in feeding and locomotion induced by amphetamine analogs in rats. | Wellman PJ et al. | β | 2009 | β |
| Cocaine-conditioned locomotion in dopamine transporter, norepinephrine transporter and 5-HT transporter knockout mice. | Hall FS et al. | β | 2009 | β |
| Cocaine does not produce reward in absence of dopamine transporter inhibition. | Tilley MR et al. | β | 2009 | β |
| Cocaine modulates locomotion behavior in C. elegans. | Ward A et al. | β | 2009 | β |
| Dramatically decreased cocaine self-administration in dopamine but not serotonin transporter knock-out mice. | Thomsen M et al. | β | 2009 | β |
| Functional mutations in mouse norepinephrine transporter reduce sensitivity to cocaine inhibition. | Wei H et al. | β | 2009 | β |
| Getting specialized: presynaptic and postsynaptic dopamine D2 receptors. | De Mei C et al. | β | 2009 | β |
| Lack of cocaine self-administration in mice expressing a cocaine-insensitive dopamine transporter. | Thomsen M et al. | β | 2009 | β |
| Norepinephrine and stimulant addiction. | Sofuoglu M et al. | β | 2009 | β |
| Pharmacotherapy of addictive disorders. | Ross S et al. | β | 2009 | β |
| Synthesis and structure-activity relationship of 3beta-(4-alkylthio, -methylsulfinyl, and -methylsulfonylphenyl)tropane and 3beta-(4-alkylthiophenyl)nortropane derivatives for monoamine transporters. | Jin C et al. | β | 2009 | β |
| The genetic basis of individual differences in reward processing and the link to addictive behavior and social cognition. | Yacubian J et al. | β | 2009 | β |
| Vesicular monoamine transporter 2 and dopamine transporter are molecular targets of Pitx3 in the ventral midbrain dopamine neurons. | Hwang DY et al. | β | 2009 | β |
| A unified framework for addiction: vulnerabilities in the decision process. | Redish AD et al. | β | 2008 | β |
| [Current preclinical knowledge of the neurobiology of cocaine]. | Noble F | β | 2008 | β |
| Design and synthesis of 2- and 3-substituted-3-phenylpropyl analogs of 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine and 1-[2-(diphenylmethoxy)ethyl]-4-(3-phenylpropyl)piperazine: role of amino, fluoro, hydroxyl, methoxyl, methyl, methylene, and oxo substituents on affinity for the dopamine and serotonin transporters. | Hsin LW et al. | β | 2008 | β |
| Differential cocaine-induced modulation of glutamate and dopamine transporters after contingent and non-contingent administration. | MiguΓ©ns M et al. | β | 2008 | β |
| Dopaminergic and brain-derived neurotrophic factor signalling in inbred mice exposed to a restricted feeding schedule. | Gelegen C et al. | β | 2008 | β |
| Dopamine transporter mutant mice in experimental neuropharmacology. | Gainetdinov RR | β | 2008 | β |
| Genetic NMDA receptor deficiency disrupts acute and chronic effects of cocaine but not amphetamine. | Ramsey AJ et al. | β | 2008 | β |
| In vivo characterization of a novel phenylisothiocyanate tropane analog at monoamine transporters in rat brain. | Murthy V et al. | β | 2008 | β |
| Long-term administration of cocaine or serotonin reuptake inhibitors results in anatomical and neurochemical changes in noradrenergic, dopaminergic, and serotonin pathways. | Horne MK et al. | β | 2008 | β |
| Role of the dopamine transporter in the action of psychostimulants, nicotine, and other drugs of abuse. | Zhu J et al. | β | 2008 | β |
| Synthesis and monoamine transporter binding properties of 2beta-[3'-(substituted benzyl)isoxazol-5-yl]- and 2beta-[3'-methyl-4'-(substituted phenyl)isoxazol-5-yl]-3beta-(substituted phenyl)tropanes. | Jin C et al. | β | 2008 | β |
| The effects of cocaine on regional brain glucose metabolism is attenuated in dopamine transporter knockout mice. | Thanos PK et al. | β | 2008 | β |
| The effects of methylphenidate on knockin mice with a methylphenidate-resistant dopamine transporter. | Tilley MR et al. | β | 2008 | β |
| The neurocircuitry of addiction: an overview. | Feltenstein MW et al. | β | 2008 | β |
| Twenty years of dopamine research: individual differences in the response of accumbal dopamine to environmental and pharmacological challenges. | Verheij MM et al. | β | 2008 | β |
| Absence of dopamine D2 receptors unmasks an inhibitory control over the brain circuitries activated by cocaine. | Welter M et al. | β | 2007 | β |
| Cocaine-conditioned place preference by dopamine-deficient mice is mediated by serotonin. | Hnasko TS et al. | β | 2007 | β |
| Cocaine reward and locomotion stimulation in mice with reduced dopamine transporter expression. | Tilley MR et al. | β | 2007 | β |
| Dopamine uptake inhibition is positively correlated with cocaine-induced stereotyped behavior. | Budygin EA | β | 2007 | β |
| Effects of acute "binge" cocaine on mRNA levels of mu opioid receptor and neuropeptides in dopamine D1 or D3 receptor knockout mice. | Zhou Y et al. | β | 2007 | β |
| Effects of cocaine on monoamine uptake as measured ex vivo. | Wang Z et al. | β | 2007 | β |
| Genetics of dopamine and its contribution to cocaine addiction. | Haile CN et al. | β | 2007 | β |
| Increased dopamine D2High receptors in knockouts of the dopamine transporter and the vesicular monoamine transporter may contribute to spontaneous hyperactivity and dopamine supersensitivity. | Seeman P et al. | β | 2007 | β |
| Lack of self-administration of cocaine in dopamine D1 receptor knock-out mice. | Caine SB et al. | β | 2007 | β |
| Monoamine transporter as a target molecule for psychostimulants. | Sora I et al. | β | 2007 | β |
| Parallel loss of hippocampal LTD and cognitive flexibility in a genetic model of hyperdopaminergia. | Morice E et al. | β | 2007 | β |
| Previous exposure to cocaine enhances cocaine self-administration in an alpha 1-adrenergic receptor dependent manner. | Zhang XY et al. | β | 2007 | β |
| Serotonin and psychostimulant addiction: focus on 5-HT1A-receptors. | MΓΌller CP et al. | β | 2007 | β |
| Synthesis of 8-thiabicyclo[3.2.1]octanes and their binding affinity for the dopamine and serotonin transporters. | Pham-Huu DP et al. | β | 2007 | β |
| Voltammetric characterization of the effect of monoamine uptake inhibitors and releasers on dopamine and serotonin uptake in mouse caudate-putamen and substantia nigra slices. | John CE et al. | β | 2007 | β |
| Abolished cocaine reward in mice with a cocaine-insensitive dopamine transporter. | Chen R et al. | β | 2006 | β |
| Behavioral electrophysiology of psychostimulants. | Rebec GV | β | 2006 | β |
| Corticostriatal up-regulation of activity-regulated cytoskeletal-associated protein expression after repeated exposure to cocaine. | Fumagalli F et al. | β | 2006 | β |
| Cumulative effect of norepinephrine and dopamine carrier blockade on extracellular dopamine increase in the nucleus accumbens shell, bed nucleus of stria terminalis and prefrontal cortex. | Carboni E et al. | β | 2006 | β |
| Design, synthesis, and preliminary SAR study of 3- and 6-side-chain-extended tetrahydro-pyran analogues of cis- and trans-(6-benzhydryl-tetrahydropyran-3-yl)-benzylamine. | Zhang S et al. | β | 2006 | β |
| Dopamine-1 receptor agonist, but not cocaine, modulates sigma(1) gene expression in SVG cells. | Ben-Ami O et al. | β | 2006 | β |
| Fluoxetine as a potential pharmacotherapy for methamphetamine dependence: studies in mice. | Takamatsu Y et al. | β | 2006 | β |
| Methamphetamine reward in mice as assessed by conditioned place preference test with Supermex sensors: effect of subchronic clorgyline pretreatment. | Kitanaka N et al. | β | 2006 | β |
| Neurorobiology and evidence-based biological treatments for substance abuse disorders. | Ivanov IS et al. | β | 2006 | β |
| Neurotransmitter transporters and their impact on the development of psychopharmacology. | Iversen L | β | 2006 | β |
| [New developments in the pharmacotherapy of cocaine dependence]. | Wiesbeck G et al. | β | 2006 | β |
| PI3 kinase is involved in cocaine behavioral sensitization and its reversal with brain area specificity. | Zhang X et al. | β | 2006 | β |
| Relapse of methamphetamine-seeking behavior in C57BL/6J mice demonstrated by a reinstatement procedure involving intravenous self-administration. | Yan Y et al. | β | 2006 | β |
| The mechanistic classification of addictive drugs. | LΓΌscher C et al. | β | 2006 | β |
| The role of peripheral and central sodium channels in mediating brain temperature fluctuations induced by intravenous cocaine. | Kiyatkin EA et al. | β | 2006 | β |
| Antidepressants and the monoamine masquerade. | Sulzer D et al. | β | 2005 | β |
| A triple mutation in the second transmembrane domain of mouse dopamine transporter markedly decreases sensitivity to cocaine and methylphenidate. | Chen R et al. | β | 2005 | β |
| Bilateral control of brain activity by dopamine D1 receptors: evidence from induction patterns of regulator of G protein signaling 2 and c-fos mRNA in D1-challenged hemiparkinsonian rats. | Taymans JM et al. | β | 2005 | β |
| Block of a Ca(2+)-activated potassium channel by cocaine. | Premkumar LS | β | 2005 | β |
| Characterization of conditioned place preference to cocaine in congenic dopamine transporter knockout female mice. | Medvedev IO et al. | β | 2005 | β |
| Defunctionalized lobeline analogues: structure-activity of novel ligands for the vesicular monoamine transporter. | Zheng G et al. | β | 2005 | β |
| Genetic susceptibility to substance dependence. | Hiroi N et al. | β | 2005 | β |
| Pharmacogenetics and human molecular genetics of opiate and cocaine addictions and their treatments. | Kreek MJ et al. | β | 2005 | β |
| Regulation of monoamine transporters: influence of psychostimulants and therapeutic antidepressants. | Jayanthi LD et al. | β | 2005 | β |
| The role of dopamine in reward and pleasure behaviour--review of data from preclinical research. | Bressan RA et al. | β | 2005 | β |
| Altered neurotensin mrna expression in mice lacking the dopamine transporter. | Roubert C et al. | β | 2004 | β |
| Dissociation of rewarding and dopamine transporter-mediated properties of amphetamine. | Budygin EA et al. | β | 2004 | β |
| Dopamine and glutamate control area-restricted search behavior in Caenorhabditis elegans. | Hills T et al. | β | 2004 | β |
| Dopamine, learning and motivation. | Wise RA | β | 2004 | β |
| Dopamine receptor-mediated regulation of RGS2 and RGS4 mRNA differentially depends on ascending dopamine projections and time. | Taymans JM et al. | β | 2004 | β |
| Genetic and genomic approaches to reward and addiction. | Mohn AR et al. | β | 2004 | β |
| Individual differences in cocaine- and amphetamine-induced activation of male Sprague-Dawley rats: contribution of the dopamine transporter. | Briegleb SK et al. | β | 2004 | β |
| Isoflurane alters the amount of dopamine transporter expressed on the plasma membrane in humans. | Votaw JR et al. | β | 2004 | β |
| Lobeline analogs with enhanced affinity and selectivity for plasmalemma and vesicular monoamine transporters. | Miller DK et al. | β | 2004 | β |
| Molecular mechanisms underlying the rewarding effects of cocaine. | Hall FS et al. | β | 2004 | β |
| mu-Opioid receptor knockout mice display reduced cocaine conditioned place preference but enhanced sensitization of cocaine-induced locomotion. | Hall FS et al. | β | 2004 | β |
| Neurobiologic processes in drug reward and addiction. | Adinoff B | β | 2004 | β |
| Regional differences in extracellular dopamine and serotonin assessed by in vivo microdialysis in mice lacking dopamine and/or serotonin transporters. | Shen HW et al. | β | 2004 | β |
| Rewarding effects elicited by cocaine microinjections into the ventral tegmental area of C57BL/6 mice: involvement of dopamine D1 and serotonin1B receptors. | David V et al. | β | 2004 | β |
| Role of serotonin in cocaine effects in mice with reduced dopamine transporter function. | Mateo Y et al. | β | 2004 | β |
| Role of serotonin on cocaine-mediated effects on prodynorphin gene expression in the rat brain. | Di Benedetto M et al. | β | 2004 | β |
| Structural requirements for 2,4- and 3,6-disubstituted pyran biomimetics of cis-(6-benzhydryl-piperidin-3-yl)-benzylamine compounds to interact with monoamine transporters. | Zhang S et al. | β | 2004 | β |
| Synthesis of 8-thiabicyclo[3.2.1]oct-2-enes and their binding affinity for the dopamine and serotonin transporters. | Meltzer PC et al. | β | 2004 | β |
| Ultrastructural evidence for co-localization of dopamine D2 and micro-opioid receptors in the rat dorsolateral striatum. | Ambrose LM et al. | β | 2004 | β |
| Uptake and release of norepinephrine by serotonergic terminals in norepinephrine transporter knock-out mice: implications for the action of selective serotonin reuptake inhibitors. | Vizi ES et al. | β | 2004 | β |
| Voltammetric assessment of dopamine clearance in the absence of the dopamine transporter: no contribution of other transporters in core or shell of nucleus accumbens. | Mateo Y et al. | β | 2004 | β |
| Acquisition of lever pressing for cocaine in C57BL/6J mice: effects of prior Pavlovian conditioning. | Griffin WC et al. | β | 2003 | β |
| BP 897, a selective dopamine D3 receptor ligand with therapeutic potential for the treatment of cocaine-addiction. | Garcia-Ladona FJ et al. | β | 2003 | β |
| Cardiovascular disorders associated with cocaine use: myths and truths. | Knuepfer MM | β | 2003 | β |
| Characterization of a functional bacterial homologue of sodium-dependent neurotransmitter transporters. | Androutsellis-Theotokis A et al. | β | 2003 | β |
| Conditioned stimulus-induced reinstatement of extinguished cocaine seeking in C57BL/6 mice: a mouse model of drug relapse. | Fuchs RA et al. | β | 2003 | β |
| Decreased cocaine self-administration in Kir3 potassium channel subunit knockout mice. | Morgan AD et al. | β | 2003 | β |
| Design, synthesis, and activity of novel cis- and trans-3,6-disubstituted pyran biomimetics of 3,6-disubstituted piperidine as potential ligands for the dopamine transporter. | Zhang S et al. | β | 2003 | β |
| Dopaminergic mouse mutants: investigating the roles of the different dopamine receptor subtypes and the dopamine transporter. | Tan S et al. | β | 2003 | β |
| Dopamine transporter as target for drug development of cocaine dependence medications. | Dutta AK et al. | β | 2003 | β |
| Dual modulation of gabaergic transmission by metabotropic glutamate receptors in rat ventral tegmental area. | Zheng F et al. | β | 2003 | β |
| Dynamic regulation of the dopamine transporter. | Mortensen OV et al. | β | 2003 | β |
| Enhanced rewarding properties of morphine, but not cocaine, in beta(arrestin)-2 knock-out mice. | Bohn LM et al. | β | 2003 | β |
| Individual differences in cocaine-induced locomotor activity in rats: behavioral characteristics, cocaine pharmacokinetics, and the dopamine transporter. | Gulley JM et al. | β | 2003 | β |
| Invertebrate models of drug abuse. | Wolf FW et al. | β | 2003 | β |
| Mixed cocaine agonist/antagonist properties of (+)-methyl 4beta-(4-chlorophenyl)-1-methylpiperidine-3alpha-carboxylate, a piperidine-based analog of cocaine. | Kozikowski AP et al. | β | 2003 | β |
| Pharmacogenetics of monoamine transporters. | Glatt CE et al. | β | 2003 | β |
| Plasma membrane monoamine transporters: structure, regulation and function. | Torres GE et al. | β | 2003 | β |
| Presynaptic regulation of dopaminergic neurotransmission. | Schmitz Y et al. | β | 2003 | β |
| Reduced behavioral effects of cocaine in heterozygous brain-derived neurotrophic factor (BDNF) knockout mice. | Hall FS et al. | β | 2003 | β |
| Serotonin1A-receptor agonism attenuates the cocaine-induced increase in serotonin levels in the hippocampus and nucleus accumbens but potentiates hyperlocomotion: an in vivo microdialysis study. | MΓΌller CP et al. | β | 2003 | β |
| Sigma receptors: potential medications development target for anti-cocaine agents. | Matsumoto RR et al. | β | 2003 | β |
| The A9 allele of the dopamine transporter gene is associated with delirium tremens and alcohol-withdrawal seizure. | Gorwood P et al. | β | 2003 | β |
| A cocaine insensitive chimeric insect serotonin transporter reveals domains critical for cocaine interaction. | Sandhu SK et al. | β | 2002 | β |
| Alpha1b-adrenergic receptors control locomotor and rewarding effects of psychostimulants and opiates. | Drouin C et al. | β | 2002 | β |
| Behavioral consequences of methamphetamine-induced neurotoxicity in mice: relevance to the psychopathology of methamphetamine addiction. | Itzhak Y et al. | β | 2002 | β |
| Behavioral pharmacologists: don't just say "no" to knockout mice. Commentary on Stephens et al. 'Studying the neurobiology of stimulant and alcohol abuse and dependence in genetically manipulated mice'. | Caine SB et al. | β | 2002 | β |
| Cocaine increases serotonergic activity in the hippocampus and nucleus accumbens in vivo: 5-HT1a-receptor antagonism blocks behavioral but potentiates serotonergic activation. | MΓΌller CP et al. | β | 2002 | β |
| Cocaine, reward, movement and monoamine transporters. | Uhl GR et al. | β | 2002 | β |
| Dopamine-dependent desensitization of dopaminergic signaling in the developing mouse striatum. | Kim DS et al. | β | 2002 | β |
| Dopamine uptake through the norepinephrine transporter in brain regions with low levels of the dopamine transporter: evidence from knock-out mouse lines. | MorΓ³n JA et al. | β | 2002 | β |
| Elevated expression of 5-HT1B receptors in nucleus accumbens efferents sensitizes animals to cocaine. | Neumaier JF et al. | β | 2002 | β |
| Enhanced locomotor, reinforcing, and neurochemical effects of cocaine in serotonin 5-hydroxytryptamine 2C receptor mutant mice. | Rocha BA et al. | β | 2002 | β |
| Involvement of serotonin in nicotine dependence: processes relevant to positive and negative regulation of drug intake. | Olausson P et al. | β | 2002 | β |
| Methamphetamine-induced dopaminergic neurotoxicity in mice: long-lasting sensitization to the locomotor stimulation and desensitization to the rewarding effects of methamphetamine. | Itzhak Y et al. | β | 2002 | β |
| Monoamine transporter pharmacology and mutant mice. | Gainetdinov RR et al. | β | 2002 | β |
| Pharmacotherapy of addictions. | Kreek MJ et al. | β | 2002 | β |
| Probes for the dopamine transporter: new leads toward a cocaine-abuse therapeutic--A focus on analogues of benztropine and rimcazole. | Newman AH et al. | β | 2002 | β |
| Role of dopamine D2-like receptors in cocaine self-administration: studies with D2 receptor mutant mice and novel D2 receptor antagonists. | Caine SB et al. | β | 2002 | β |
| [Role of dopamine in drug dependence processes]. | Tassin JP | β | 2002 | β |
| Studying the neurobiology of stimulant and alcohol abuse and dependence in genetically manipulated mice. | Stephens DN et al. | β | 2002 | β |
| [Advanced findings on the molecular mechanisms for behavioral sensitization to psychostimulants]. | Ujike H | β | 2001 | β |
| Altering behavioral responses and dopamine transporter protein with antisense peptide nucleic acids. | Tyler-McMahon BM et al. | β | 2001 | β |
| Biophysical characterization of the cocaine binding pocket in the serotonin transporter using a fluorescent cocaine analogue as a molecular reporter. | Rasmussen SG et al. | β | 2001 | β |
| Differential behavioral responses to cocaine are associated with dynamics of mesolimbic dopamine proteins in Lewis and Fischer 344 rats. | Haile CN et al. | β | 2001 | β |
| Differential time-course profiles of dopamine release and uptake changes induced by three dopamine uptake inhibitors. | Lee TH et al. | β | 2001 | β |
| Glutamatergic modulation of hyperactivity in mice lacking the dopamine transporter. | Gainetdinov RR et al. | β | 2001 | β |
| Hypolocomotor effects of acute and daily d-amphetamine in mice lacking the dopamine transporter. | Spielewoy C et al. | β | 2001 | β |
| Locomotor stimulant effects of novel phenyltropanes in the mouse. | Kimmel HL et al. | β | 2001 | β |
| Molecular mechanisms of cocaine reward: combined dopamine and serotonin transporter knockouts eliminate cocaine place preference. | Sora I et al. | β | 2001 | β |
| Plasticity in serotonin uptake in primary neuronal cultures of serotonin transporter knockout mice. | Pan Y et al. | β | 2001 | β |
| Prenatal cocaine exposure produces consistent developmental alterations in dopamine-rich regions of the cerebral cortex. | Stanwood GD et al. | β | 2001 | β |
| Regulation of opioid receptors by cocaine. | Unterwald EM | β | 2001 | β |
| Rimcazole analogs attenuate the convulsive effects of cocaine: correlation with binding to sigma receptors rather than dopamine transporters. | Matsumoto RR et al. | β | 2001 | β |
| Subtle differences in the discriminative stimulus effects of cocaine and GBR-12909. | Tella SR et al. | β | 2001 | β |
| Synthesis of 6- and 7- hydroxy-8-azabicyclo[3.2.1]octanes and their binding affinity for the dopamine and serotonin transporters. | Meltzer PC et al. | β | 2001 | β |
| Basal and cocaine-induced opioid receptor gene expression in the rat CNS analyzed by competitive reverse transcription PCR. | Rosin A et al. | β | 2000 | β |
| Dopamine release and uptake dynamics within nonhuman primate striatum in vitro. | Cragg SJ et al. | β | 2000 | β |
| Dual serotonin (5-HT) projections to the nucleus accumbens core and shell: relation of the 5-HT transporter to amphetamine-induced neurotoxicity. | Brown P et al. | β | 2000 | β |
| Effects of intravenous cocaine administration on cerebellar Purkinje cell activity. | JimΓ©nez-Rivera CA et al. | β | 2000 | β |
| Fluorine-18-labeled tropane analogs for PET imaging studies of the dopamine transporter. | Mach RH et al. | β | 2000 | β |
| Genes and addiction. | Nestler EJ | β | 2000 | β |
| Homeostatic regulation of serotonergic function by the serotonin transporter as revealed by nonviral gene transfer. | Fabre V et al. | β | 2000 | β |
| Increased rewarding properties of morphine in dopamine-transporter knockout mice. | Spielewoy C et al. | β | 2000 | β |
| Lack of response suppression follows repeated ventral tegmental cannabinoid administration: an in vitro electrophysiological study. | Cheer JF et al. | β | 2000 | β |
| Mice lacking the norepinephrine transporter are supersensitive to psychostimulants. | Xu F et al. | β | 2000 | β |
| Modulation of the effects of cocaine by 5-HT1B receptors: a comparison of knockouts and antagonists. | Castanon N et al. | β | 2000 | β |
| Molecular and regional targets of cocaine in primate brain: liberation from prosaic views. | Madras BK et al. | β | 2000 | β |
| Neurotransmitter transporters: fruitful targets for CNS drug discovery. | Iversen L | β | 2000 | β |
| Opiate drugs: 'guilt by association'. | Evans CJ et al. | β | 2000 | β |
| Phasic inhibition of dopamine uptake in nucleus accumbens induced by intravenous cocaine in freely behaving rats. | Kiyatkin EA et al. | β | 2000 | β |
| Serotonin transporters upregulate with chronic cocaine use. | Mash DC et al. | β | 2000 | β |
| Structural domains of chimeric dopamine-noradrenaline human transporters involved in the Na(+)- and Cl(-)-dependence of dopamine transport. | Syringas M et al. | β | 2000 | β |
| Unexpected findings | McMillen BA | β | 2000 | β |
| A cognate dopamine transporter-like activity endogenously expressed in a COS-7 kidney-derived cell line. | Sugamori KS et al. | β | 1999 | β |
| Amphetamine depresses excitatory synaptic transmission via serotonin receptors in the ventral tegmental area. | Jones S et al. | β | 1999 | β |
| Chronic methylphenidate alters locomotor activity and dopamine transporters differently from cocaine. | Izenwasser S et al. | β | 1999 | β |
| Cocaine Addiction: Neurobiology and Related Current Research in Pharmacotherapy. | Panikkar GP | β | 1999 | β |
| Cocaine reward and MPTP toxicity: alteration by regional variant dopamine transporter overexpression. | Donovan DM et al. | β | 1999 | β |
| Differential binding of tropane-based photoaffinity ligands on the dopamine transporter. | Vaughan RA et al. | β | 1999 | β |
| Differential regulation of tyrosine hydroxylase in the basal ganglia of mice lacking the dopamine transporter. | Jaber M et al. | β | 1999 | β |
| Dissociation of dopamine release in the nucleus accumbens from intracranial self-stimulation. | Garris PA et al. | β | 1999 | β |
| Dopaminergic agents for the treatment of cocaine abuse. | Smith MP et al. | β | 1999 | β |
| Drugs of abuse and brain gene expression. | Torres G et al. | β | 1999 | β |
| Evidence for the sequential formation of two complexes between an uptake inhibitor, GBR 12783 [1-[2-(diphenylmethoxy)ethyl]-4-(3-phenyl-2-propenyl)piperazine], and the neuronal transporter of dopamine. | Do-RΓ©go JC et al. | β | 1999 | β |
| Mechanisms of action of drugs of abuse on the developing fetal brain. | Malanga CJ et al. | β | 1999 | β |
| Molecular manipulations as tools for enhancing our understanding of 5-HT neurotransmission. | Murphy DL et al. | β | 1999 | β |
| Neurobiology of tobacco smoking and other addictive disorders. | Gamberino WC et al. | β | 1999 | β |
| Phosphorylation and sequestration of serotonin transporters differentially modulated by psychostimulants. | Ramamoorthy S et al. | β | 1999 | β |
| Role of serotonin in the paradoxical calming effect of psychostimulants on hyperactivity. | Gainetdinov RR et al. | β | 1999 | β |
| The EGR family of transcription-regulatory factors: progress at the interface of molecular and systems neuroscience. | O'Donovan KJ et al. | β | 1999 | β |
| Electrophysiological characterization of GABAergic neurons in the ventral tegmental area. | Steffensen SC et al. | β | 1998 | β |
| Neuroscience of addiction. | Koob GF et al. | β | 1998 | β |
| Rational treatment of addiction. | Terenius L | β | 1998 | β |
| Receptor systems participating in nicotine-specific effects. | SzirΓ‘ki I et al. | β | 1998 | β |
| The 5-HT3 receptor antagonist, MDL 72222, dose-dependently potentiates morphine-induced immediate-early gene expression in the rat caudate putamen. | Frankel PS et al. | β | 1998 | β |